D M Murtazalieva

Plain English
This study examined the use of a direct approach to the carotid artery for treating ischemic stroke in patients who had difficulty accessing the artery using standard methods. Out of 613 patients treated, 17 underwent this direct carotid access, with a success rate of 95% for restoring blood flow and a first-pass success rate of 82%. Importantly, the procedure was performed within an average of 62 minutes, which is crucial for improving patient outcomes. Who this helps: This benefits patients suffering from ischemic stroke, particularly those with complex anatomy that makes traditional treatment difficult.

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

Plain English
This study looked at how well a drug called Revelisa works for treating ischemic stroke in 72 patients who received treatment within 4.5 hours of their stroke. The results showed significant improvements in patients' neurological scores, with 34.7% showing at least a 4-point improvement within 24 hours, and 68.1% achieving good recovery after 30 days. There were very few side effects, with only 5.6% experiencing minor bleeding and just one patient dying, indicating that Revelisa is both effective and safe for stroke treatment. Who this helps: This benefits patients suffering from ischemic stroke.